|
|
RICT 2007 - Drug Discovery and Selection |
| Cancer |
04/07/2007
15:05 | Discovery and Optimisation of Pyrazole Inhibitors of HSP90 |
Dr. Ted MCDONALD
(INSTITUTE FOR CANCER RESEARCH, Sutton, United Kingdom) |
05/07/2007
09:05 | Natural Product Inspired Isoform Selective Histone Deacetylase Inhibitors |
Dr. A. GANESAN
(UNIVERSITY OF SOUTHAMPTON, Southampton, United Kingdom) |
05/07/2007
10:45 | The Discovery of AZD0530: A Novel, Oral, Highly Selective SRC Inhibitor with BCR-ABL Activity |
Dr Laurent HENNEQUIN
(ASTRAZENECA, Reims, France) |
05/07/2007
17:00 | Metathesis and Synthesis of Anticancer Agents |
Prof. Janine COSSY
(ESPCI PARISTECH, Paris, France) |
| Cardiovascular |
04/07/2007
10:50 | Opening the Gate to Novel Ion Channel Modulators and Innovative Anti-arrhythmics |
Dr. Petra BLOM
(DEVGEN, Zwijnaarde, Belgium) |
06/07/2007
09:05 | In Silico Predicitions of Cardiovascular Safety - Beyond hERG |
Dr. Luca FENU
(JOHNSON & JOHNSON PRD, Beerse, Belgium) |
| CNS |
05/07/2007
15:50 | The Discovery and Development of a Green Process for Radafaxine |
Dr. Trevor J. GRINTER
(GLAXO SMITH KLINE, Tonbridge, United Kingdom) |
06/07/2007
13:55 | From Medicinal Chemistry to New Targets and New Drugs. Discovery of New Antiepileptic Drug Candidates. |
Dr Benoit KENDA
(UCB, Braine-l'Alleud, Belgium) |
| Coagulation |
04/07/2007
16:45 | Synthesis and Structure-Activity Relationships of Oral Venous Antithrombotic Thioglycosylated Derivatives |
Dr. Véronique BARBEROUSSE
(ABBOTT - LABORATOIRE FOURNIER, , France) |
| Hematology |
06/07/2007
15:15 | Discovery of Eltrombopag, a Small-Molecule Oral Thrombopoietin Receptor Agonist: a Modulator of a Protein-Protein Interaction |
Dr. Juan LUENGO
(GLAXO SMITH KLINE, Collegeville, United States) |
| Metabolic Disorder |
04/07/2007
11:25 | From Compound to Targets to Compounds: The Example of the PPARs |
Prof. Bart STAELS
(INSTITUT PASTEUR DE LILLE, Lille, France) |
06/07/2007
10:45 | Long Duration of Action by Design: Discovery of Degarelix, a Self-Depoting GnRH Blocker
|
Dr. Claudio SCHTEINGART
(FERRING RESEARCH INSTITUTE, San Diego, CA, United States) |
06/07/2007
11:35 | Concept and Development of Chimeric Molecules: Somatostatin –Dopamine Chimeras |
Dr. Christophe THURIEAU
(GROUP IPSEN, Les Ulis, France) |
06/07/2007
12:15 | Therapeutic proteins : Role of Post-Translational Modifications in Structure-Function Relationships. Application to Monoclonal Antibodies and Coagulation Factors |
Dr. Laurent SIRET
(LFB, Courtabœuf, France) |
| Protease Inhibitors |
05/07/2007
09:40 | The Evolution of a Series of Small Molecule Inhibitors of Neutral Endopeptidase |
Dr David PRYDE
(PFIZER GLOBAL R&D, Sandwich, United Kingdom) |
| <Previous page |
